Evidence map›Paper›PMID 35447119›Full record

ArticleThe Journal of biological chemistry2022

Elucidation of physico-chemical principles of high-density lipoprotein-small RNA binding interactions.

Danielle L Michell, Ryan M Allen, Ashley B Cavnar, Danielle M Contreras, Minzhi Yu, Elizabeth M Semler, Clark Massick, Chase A Raby, Mark Castleberry, Marisol A Ramirez and 10 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 3 institutions in 1 country.

Danielle L MichellDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: danielle.michell@vumc.org.
Ryan M AllenDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Ashley B CavnarDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Danielle M ContrerasDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Minzhi YuDepartment of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Elizabeth M SemlerDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.
Clark MassickDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Chase A RabyDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Mark CastleberryDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Marisol A RamirezDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Wanying ZhuDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Linda May-ZhangDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.
Anca IfrimDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
John Jeffrey CarrDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Tennessee, USA.
James G TerryDepartment of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Tennessee, USA.
Anna SchwendemanDepartment of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Sean S DaviesDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.
Quanhu ShengDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
MacRae F LintonDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Kasey C VickersDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA. Electronic address: kasey.c.vickers@vumc.org.
Vanderbilt University Medical Center · USVanderbilt University · USUniversity of Michigan · US

Funding

Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LINTON, MACRAE F · 2014 to 2025
$24.7M
Roles for Supermeres in CRC ProgressionP01CA229123 · NCI · VANDERBILT UNIVERSITY · PI Alissa M Weaver · 2020 to 2026
$12.9M
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted TherapyR01CA260958 · NCI · VANDERBILT UNIVERSITY · PI COOK, REBECCA SARA, DUVALL, CRAIG LEWIS · 2021 to 2025
$3.0M
HDL-microRNA Intercellular Communication in AtherosclerosisR01HL128996 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI VICKERS, KASEY C · 2015 to 2019
$2.3M
Uncovering exRNA and protein determinants of secreted vesicle heterogeneity by flow cytometric purification of vesicle subsets from cells and plasmaUH3CA241685 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CHAREST, ALAIN, COFFEY, ROBERT J. · 2021 to 2022
$2.1M
NCI NIH HHS P01 CA229123NCI NIH HHS R01 CA260958NCI NIH HHS UH3 CA241685NHLBI NIH HHS P01 HL116263NHLBI NIH HHS R01 HL128996
6 · The paper itself

Abstract

Extracellular small RNAs (sRNAs) are abundant in many biofluids, but little is known about their mechanisms of transport and stability in RNase-rich environments. We previously reported that high-density lipoproteins (HDLs) in mice were enriched with multiple classes of sRNAs derived from the endogenous transcriptome, but also from exogenous organisms. Here, we show that human HDL transports tRNA-derived sRNAs (tDRs) from host and nonhost species, the profiles of which were found to be altered in human atherosclerosis. We hypothesized that HDL binds to tDRs through apolipoprotein A-I (apoA-I) and that these interactions are conferred by RNA-specific features. We tested this using microscale thermophoresis and electrophoretic mobility shift assays and found that HDL binds to tDRs and other single-stranded sRNAs with strong affinity but did not bind to double-stranded RNA or DNA. Furthermore, we show that natural and synthetic RNA modifications influenced tDR binding to HDL. We demonstrate that reconstituted HDL bound to tDRs only in the presence of apoA-I, and purified apoA-I alone were able to bind sRNA. Conversely, phosphatidylcholine vesicles did not bind tDRs. In summary, we conclude that HDL binds to single-stranded sRNAs likely through nonionic interactions with apoA-I. These results highlight binding properties that likely enable extracellular RNA communication and provide a foundation for future studies to manipulate HDL-sRNA interactions for therapeutic approaches to prevent or treat disease.

Indexed as

Lipoproteins, HDLRNA, Small UntranslatedAnimalsApolipoprotein A-IAtherosclerosisHumansMicePhosphatidylcholinesApolipoprotein A-ILipoproteins, HDLPhosphatidylcholinesRNA, Small Untranslatedapolipoprotein A-IatherosclerosisHDLRNA binding proteintRNA

Identifiers

PMID35447119
PMCPMC9133651
OpenAlexW4224218566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.